glp-1 constipation lawsuit in west virginia With over 2,000 lawsuits filed and 25,000 ER visits linked to these drugs, we need to talk about the risks that weren't fully disclosed. I'm not against Ozempic. But I do think Ozempic's double-sided coin: Amid skyrocketing

Studies in the literature addressing the unconventional use of GLP-1 analogs are still scarce and have been performed primarily on animal models

Her doctor fought to keep her on the GLP-1 agonist, the category that includes weight loss and Type 2 diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound

the STEP 5 trial represents the most extensive study on the use of semaglutide for weight management to date

By reducing the inflammatory load of adipose tissue, weight loss and adipokine normalization may therefore represent an indirect but clinically meaningful mechanism by which GLP-1RAs influence thyroid autoimmunity

In agreement with expectations, the first outcome trial of a GLP-1RA, the ELIXA trial of the short-acting lixisenatide, an exendin-4 derivative with properties almost identical to those of exendin-4 or exenatide (stable, full agonists of the GLP-1 receptor), showed no increased cardiovascular risk in a patient group with severely increased CVD risk